Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade
By Clifford R. Jack Jr., David S. Knopman, William J. Jagust, Leslie M. Shaw, P. Aisen, Michael W. Weiner, Ronald C. Petersen, John Q. Trojanowski. Lancet Neurology, 2010
4,709 citations recorded by the source corpus.
Currently available evidence strongly supports the position that the initiating event in Alzheimer’s disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately leading to formation of Aβ plaques in the brain. This process occurs while individuals are still cognitively normal. Biomarkers of brain β-amyloidosis are reductions in CSF Aβ42 and increased amyloid PET tracer retention. After a lag period, which varies from patient to patient, neuronal dysfunction and neurodegeneration become the dominant pathological processes. Biomarkers of neuronal injury and neurodegeneration are increased CSF tau and structural MRI measures of cerebral atrophy. Neurodegeneration is accompanied by synaptic dysfunction, which is indicated by decreased fluorodeoxyglucose uptake on PET. We propose a model that relates disease stage to AD biomarkers in which Aβ biomarkers become abnormal first, before neurodegenerative biomarkers and cognitive symptoms, and neurodegenerative biomarkers become abnormal later, and correlate with clinical symptom severity.
Subfields: Physiology, Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/fa9e7e5541f4f4304383fe3a987b7f3270363d98
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
- D. Holtzman
- Kaj Blennow
- Henrik Zetterberg
- Jiayu Zhou
- Clifford R. Jack Jr.
- Reisa A. Sperling
- Oskar Hansson
- Kaixiang Lin
In Psychiatry and Mental health
- Kaj Blennow
- D. Holtzman
- Henrik Zetterberg
- Jiayu Zhou
- Kaixiang Lin
- Clifford R. Jack Jr.
- Oskar Hansson
- Reisa A. Sperling
In Radiology, Nuclear Medicine and Imaging
- Jiayu Zhou
- Nicholas J. Tustison
- Brian B. Avants
- James C. Gee
- Philip Scheltens
- Jieping Ye
- Gang Song
- Harald Hampel
Citations in the corpus
- Ten-Year Effects of the ACTIVE Cognitive Training Trial on Cognition and Everyday Functioning in Older Adults (2014, background): “It is also possible that age-related structural changes in the medial temporal lobe, including age-related neuropathology and even incipient Alzheimer’s disease in some participants, limits the durability of memory training in older adults.(35,36) There are a number of possible reasons for the findi”
- Improving Mild Cognitive Impairment Prediction via Reinforcement Learning and Dialogue Simulation (2018, background): “Brain imaging, such as the structural magnetic resonance imaging (MRI), was shown to contain prime markers of AD, capturing the physiologic changes in the AD pathological process [16, 21].”
- BRAIN FUEL METABOLISM, AGING AND ALZHEIMER’S DISEASE (2010, background): “We agree that oxidative stress, mitochondrial dysfunction and mismanagement of amyloid precursor protein could contribute to synaptic failure which would further decrease brain glucose metabolism [2,38].”
- Multimodal Neuroimaging Feature Learning With Multimodal Stacked Deep Polynomial Networks for Diagnosis of Alzheimer's Disease (2018, background): “Specifically speaking, the changes in FDG-PET metabolic measures precede the changes in the brain structures of MRI for MCI patient [55].”